Global Idiopathic Pulmonary Fibrosis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 122 pages | ID: G38FC779278EN
GlobalInfoResearch

Abstracts

Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.

Scope of the Report:

This report studies the Idiopathic Pulmonary Fibrosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Idiopathic Pulmonary Fibrosis market by product type and applications/end industries.

An increase in the incidence and prevalence of fibrotic diseases is the primary driver for the growth of this market. Idiopathic pulmonary fibrosis most commonly affects middle-aged to older adults and is characterized by the scarring of lung tissues. In older people, these scars tend to build up and affect the normal functioning of lungs. Thus, an increase in aging population leads to increased prevalence of the disease, which in turn results in market growth during the predicted period.

The global Idiopathic Pulmonary Fibrosis market is valued at 1620 million USD in 2017 and is expected to reach 3120 million USD by the end of 2023, growing at a CAGR of 11.5% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Idiopathic Pulmonary Fibrosis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

• MediciNova
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• FibroGen
• Promedior
• Merck
• Galapagos
• Prometic Life Sciences
• Cipla

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Systemic Corticosteroids
• Immunosuppressant Drugs
• Tyrosine Kinase Inhibitors
• Antifibrotic Agents

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Academic and Research Organizations
  
  

Contents

1 IDIOPATHIC PULMONARY FIBROSIS MARKET OVERVIEW

1.1 Product Overview and Scope of Idiopathic Pulmonary Fibrosis
1.2 Classification of Idiopathic Pulmonary Fibrosis by Types
  1.2.1 Global Idiopathic Pulmonary Fibrosis Revenue Comparison by Types (2017-2023)
  1.2.2 Global Idiopathic Pulmonary Fibrosis Revenue Market Share by Types in 2017
  1.2.3 Systemic Corticosteroids
  1.2.4 Immunosuppressant Drugs
  1.2.5 Tyrosine Kinase Inhibitors
  1.2.6 Antifibrotic Agents
1.3 Global Idiopathic Pulmonary Fibrosis Market by Application
  1.3.1 Global Idiopathic Pulmonary Fibrosis Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Ambulatory Surgical Centers
  1.3.5 Academic and Research Organizations
1.4 Global Idiopathic Pulmonary Fibrosis Market by Regions
  1.4.1 Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Idiopathic Pulmonary Fibrosis Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Idiopathic Pulmonary Fibrosis Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Idiopathic Pulmonary Fibrosis Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Idiopathic Pulmonary Fibrosis Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Idiopathic Pulmonary Fibrosis Status and Prospect (2013-2023)
1.5 Global Market Size of Idiopathic Pulmonary Fibrosis (2013-2023)

2 MANUFACTURERS PROFILES

2.1 MediciNova
  2.1.1 Business Overview
  2.1.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 MediciNova Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
  2.2.1 Business Overview
  2.2.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
  2.3.1 Business Overview
  2.3.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 FibroGen
  2.4.1 Business Overview
  2.4.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 FibroGen Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Promedior
  2.5.1 Business Overview
  2.5.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Promedior Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
  2.6.1 Business Overview
  2.6.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Merck Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galapagos
  2.7.1 Business Overview
  2.7.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Galapagos Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.8 Prometic Life Sciences
  2.8.1 Business Overview
  2.8.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Prometic Life Sciences Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cipla
  2.9.1 Business Overview
  2.9.2 Idiopathic Pulmonary Fibrosis Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Cipla Idiopathic Pulmonary Fibrosis Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET COMPETITION, BY PLAYERS

3.1 Global Idiopathic Pulmonary Fibrosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Idiopathic Pulmonary Fibrosis Players Market Share
  3.2.2 Top 10 Idiopathic Pulmonary Fibrosis Players Market Share
3.3 Market Competition Trend

4 GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE BY REGIONS

4.1 Global Idiopathic Pulmonary Fibrosis Revenue and Market Share by Regions
4.2 North America Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
4.3 Europe Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
4.5 South America Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA IDIOPATHIC PULMONARY FIBROSIS REVENUE BY COUNTRIES

5.1 North America Idiopathic Pulmonary Fibrosis Revenue by Countries (2013-2018)
5.2 USA Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
5.3 Canada Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
5.4 Mexico Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)

6 EUROPE IDIOPATHIC PULMONARY FIBROSIS REVENUE BY COUNTRIES

6.1 Europe Idiopathic Pulmonary Fibrosis Revenue by Countries (2013-2018)
6.2 Germany Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
6.3 UK Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
6.4 France Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
6.5 Russia Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
6.6 Italy Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC IDIOPATHIC PULMONARY FIBROSIS REVENUE BY COUNTRIES

7.1 Asia-Pacific Idiopathic Pulmonary Fibrosis Revenue by Countries (2013-2018)
7.2 China Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
7.3 Japan Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
7.4 Korea Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
7.5 India Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA IDIOPATHIC PULMONARY FIBROSIS REVENUE BY COUNTRIES

8.1 South America Idiopathic Pulmonary Fibrosis Revenue by Countries (2013-2018)
8.2 Brazil Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
8.3 Argentina Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
8.4 Colombia Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE IDIOPATHIC PULMONARY FIBROSIS BY COUNTRIES

9.1 Middle East and Africa Idiopathic Pulmonary Fibrosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
9.3 UAE Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
9.4 Egypt Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)
9.6 South Africa Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2013-2018)

10 GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET SEGMENT BY TYPE

10.1 Global Idiopathic Pulmonary Fibrosis Revenue and Market Share by Type (2013-2018)
10.2 Global Idiopathic Pulmonary Fibrosis Market Forecast by Type (2018-2023)
10.3 Systemic Corticosteroids Revenue Growth Rate (2013-2023)
10.4 Immunosuppressant Drugs Revenue Growth Rate (2013-2023)
10.5 Tyrosine Kinase Inhibitors Revenue Growth Rate (2013-2023)
10.6 Antifibrotic Agents Revenue Growth Rate (2013-2023)

11 GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET SEGMENT BY APPLICATION

11.1 Global Idiopathic Pulmonary Fibrosis Revenue Market Share by Application (2013-2018)
11.2 Idiopathic Pulmonary Fibrosis Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.6 Academic and Research Organizations Revenue Growth (2013-2018)

12 GLOBAL IDIOPATHIC PULMONARY FIBROSIS MARKET SIZE FORECAST (2018-2023)

12.1 Global Idiopathic Pulmonary Fibrosis Market Size Forecast (2018-2023)
12.2 Global Idiopathic Pulmonary Fibrosis Market Forecast by Regions (2018-2023)
12.3 North America Idiopathic Pulmonary Fibrosis Revenue Market Forecast (2018-2023)
12.4 Europe Idiopathic Pulmonary Fibrosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Idiopathic Pulmonary Fibrosis Revenue Market Forecast (2018-2023)
12.6 South America Idiopathic Pulmonary Fibrosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Idiopathic Pulmonary Fibrosis Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Idiopathic Pulmonary Fibrosis Picture
Table Product Specifications of Idiopathic Pulmonary Fibrosis
Table Global Idiopathic Pulmonary Fibrosis and Revenue (Million USD) Market Split by Prod